Published: 22 September 2020
Author(s): Yuki Kataoka, Shiho Oide, Takashi Ariie, Yasushi Tsujimoto, Toshi A. Furukawa
Section: Letter to the Editor

Fast-track preprints have garnered increased attention since the COVID-19 pandemic. However, little is known about the quality of clinical research published as preprints. The objective of this study is to explore the differences in COVID-19 randomized controlled trial (RCT) articles between medRxiv and PubMed.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.